 | • レポートコード：QYR9NV17678 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、B細胞リンパ腫2阻害剤の世界市場について調査・分析し、B細胞リンパ腫2阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（併用療法、単剤療法）、用途別（慢性リンパ性白血病、小リンパ球性リンパ腫、急性骨髄性白血病）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のB細胞リンパ腫2阻害剤市場動向 ・主要企業別マーケットシェア ・B細胞リンパ腫2阻害剤の種類別市場規模2014-2019 （併用療法、単剤療法） ・B細胞リンパ腫2阻害剤の用途別市場規模2014-2019 （慢性リンパ性白血病、小リンパ球性リンパ腫、急性骨髄性白血病） ・B細胞リンパ腫2阻害剤の北米市場：主要企業・種類別/用途別市場規模 ・B細胞リンパ腫2阻害剤のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・B細胞リンパ腫2阻害剤の中国市場：主要企業・種類別/用途別市場規模 ・B細胞リンパ腫2阻害剤の日本国内市場：主要企業・種類別/用途別市場規模 ・B細胞リンパ腫2阻害剤の東南アジア市場：主要企業・種類別/用途別市場規模 ・B細胞リンパ腫2阻害剤のインド市場：主要企業・種類別/用途別市場規模 ・B細胞リンパ腫2阻害剤の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （AbbVie Inc.、F. Hoffmann-La Roche Ltd.、Santa Cruz Biotechnology、Tocris、Biovision） ・B細胞リンパ腫2阻害剤の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis.The symptoms of hematological malignancies are often mild or not apparent, which delays diagnosis and treatment. To overcome this challenge, many organizations such as KNOW AML group and market vendors have been organizing awareness campaigns, which educate patients about the symptoms and available diagnostic methods and treatment options. This factor has increased the sales of various therapeutics, including BCL-2 inhibitors, which is a crucial drug for treating indications such as chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and acute myeloid leukemia (AML). The awareness programs also conduct cancer screening and encourage people to become blood stem cell donors. This will provide significant growth opportunities to market vendors.
In 2018, the global B-cell lymphoma 2 Inhibitors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global B-cell lymphoma 2 Inhibitors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the B-cell lymphoma 2 Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
AbbVie Inc.
F. Hoffmann-La Roche Ltd.
Santa Cruz Biotechnology
Tocris
Biovision
…
Market segment by Type, the product can be split into
Combination Therapy
Monotherapy
Market segment by Application, split into
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Cute Myeloid Leukemia
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global B-cell lymphoma 2 Inhibitors status, future forecast, growth opportunity, key market and key players.
To present the B-cell lymphoma 2 Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of B-cell lymphoma 2 Inhibitors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global B-cell lymphoma 2 Inhibitors Market Size Growth Rate by Type (2014-2025)
1.4.2 Combination Therapy
1.4.3 Monotherapy
1.5 Market by Application
1.5.1 Global B-cell lymphoma 2 Inhibitors Market Share by Application (2019-2025)
1.5.2 Chronic Lymphocytic Leukemia
1.5.3 Small Lymphocytic Lymphoma
1.5.4 Cute Myeloid Leukemia
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 B-cell lymphoma 2 Inhibitors Market Size
2.2 B-cell lymphoma 2 Inhibitors Growth Trends by Regions
2.2.1 B-cell lymphoma 2 Inhibitors Market Size by Regions (2019-2025)
2.2.2 B-cell lymphoma 2 Inhibitors Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 B-cell lymphoma 2 Inhibitors Market Size by by Players
3.1.1 Global B-cell lymphoma 2 Inhibitors Revenue by by Players (2014-2019)
3.1.2 Global B-cell lymphoma 2 Inhibitors Revenue Market Share by by Players (2014-2019)
3.1.3 Global B-cell lymphoma 2 Inhibitors Market Concentration Ratio (CR5 and HHI)
3.2 B-cell lymphoma 2 Inhibitors Key Players Head office and Area Served
3.3 Key Players B-cell lymphoma 2 Inhibitors Product/Solution/Service
3.4 Date of Enter into B-cell lymphoma 2 Inhibitors Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global B-cell lymphoma 2 Inhibitors Market Size by Type (2014-2019)
4.2 Global B-cell lymphoma 2 Inhibitors Market Size by Application (2014-2019)
5 North America
5.1 North America B-cell lymphoma 2 Inhibitors Market Size (2014-2019)
5.2 B-cell lymphoma 2 Inhibitors Key Players in North America
5.3 North America B-cell lymphoma 2 Inhibitors Market Size by Type
5.4 North America B-cell lymphoma 2 Inhibitors Market Size by Application
6 Europe
6.1 Europe B-cell lymphoma 2 Inhibitors Market Size (2014-2019)
6.2 B-cell lymphoma 2 Inhibitors Key Players in Europe
6.3 Europe B-cell lymphoma 2 Inhibitors Market Size by Type
6.4 Europe B-cell lymphoma 2 Inhibitors Market Size by Application
7 China
7.1 China B-cell lymphoma 2 Inhibitors Market Size (2014-2019)
7.2 B-cell lymphoma 2 Inhibitors Key Players in China
7.3 China B-cell lymphoma 2 Inhibitors Market Size by Type
7.4 China B-cell lymphoma 2 Inhibitors Market Size by Application
8 Japan
8.1 Japan B-cell lymphoma 2 Inhibitors Market Size (2014-2019)
8.2 B-cell lymphoma 2 Inhibitors Key Players in Japan
8.3 Japan B-cell lymphoma 2 Inhibitors Market Size by Type
8.4 Japan B-cell lymphoma 2 Inhibitors Market Size by Application
9 Southeast Asia
9.1 Southeast Asia B-cell lymphoma 2 Inhibitors Market Size (2014-2019)
9.2 B-cell lymphoma 2 Inhibitors Key Players in Southeast Asia
9.3 Southeast Asia B-cell lymphoma 2 Inhibitors Market Size by Type
9.4 Southeast Asia B-cell lymphoma 2 Inhibitors Market Size by Application
10 India
10.1 India B-cell lymphoma 2 Inhibitors Market Size (2014-2019)
10.2 B-cell lymphoma 2 Inhibitors Key Players in India
10.3 India B-cell lymphoma 2 Inhibitors Market Size by Type
10.4 India B-cell lymphoma 2 Inhibitors Market Size by Application
11 Central & South America
11.1 Central & South America B-cell lymphoma 2 Inhibitors Market Size (2014-2019)
11.2 B-cell lymphoma 2 Inhibitors Key Players in Central & South America
11.3 Central & South America B-cell lymphoma 2 Inhibitors Market Size by Type
11.4 Central & South America B-cell lymphoma 2 Inhibitors Market Size by Application
12 International Players Profiles
12.1 AbbVie Inc.
12.1.1 AbbVie Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 B-cell lymphoma 2 Inhibitors Introduction
12.1.4 AbbVie Inc. Revenue in B-cell lymphoma 2 Inhibitors Business (2014-2019))
12.1.5 AbbVie Inc. Recent Development
12.2 F. Hoffmann-La Roche Ltd.
12.2.1 F. Hoffmann-La Roche Ltd. Company Details
12.2.2 Company Description and Business Overview
12.2.3 B-cell lymphoma 2 Inhibitors Introduction
12.2.4 F. Hoffmann-La Roche Ltd. Revenue in B-cell lymphoma 2 Inhibitors Business (2014-2019)
12.2.5 F. Hoffmann-La Roche Ltd. Recent Development
12.3 Santa Cruz Biotechnology
12.3.1 Santa Cruz Biotechnology Company Details
12.3.2 Company Description and Business Overview
12.3.3 B-cell lymphoma 2 Inhibitors Introduction
12.3.4 Santa Cruz Biotechnology Revenue in B-cell lymphoma 2 Inhibitors Business (2014-2019)
12.3.5 Santa Cruz Biotechnology Recent Development
12.4 Tocris
12.4.1 Tocris Company Details
12.4.2 Company Description and Business Overview
12.4.3 B-cell lymphoma 2 Inhibitors Introduction
12.4.4 Tocris Revenue in B-cell lymphoma 2 Inhibitors Business (2014-2019)
12.4.5 Tocris Recent Development
12.5 Biovision
12.5.1 Biovision Company Details
12.5.2 Company Description and Business Overview
12.5.3 B-cell lymphoma 2 Inhibitors Introduction
12.5.4 Biovision Revenue in B-cell lymphoma 2 Inhibitors Business (2014-2019)
12.5.5 Biovision Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table B-cell lymphoma 2 Inhibitors Key Market Segments
Table Key Players B-cell lymphoma 2 Inhibitors Covered
Table Global B-cell lymphoma 2 Inhibitors Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Combination Therapy Figures
Table Key Players of Combination Therapy
Figuer Monotherapy Figures
Table Key Players of Monotherapy
Table Global B-cell lymphoma 2 Inhibitors Market Size Growth by Application 2019-2025 (Million US$)
Figure Global B-cell lymphoma 2 Inhibitors Market Share by Application in 2018 & 2025
Figure Chronic Lymphocytic Leukemia Case Studies
Figure Small Lymphocytic Lymphoma Case Studies
Figure Cute Myeloid Leukemia Case Studies
Figure B-cell lymphoma 2 Inhibitors Report Years Considered
Figure Global B-cell lymphoma 2 Inhibitors Market Size and Growth Rate 2014-2025 (Million US$)
Table Global B-cell lymphoma 2 Inhibitors Market Size by Regions 2019-2025 (Million US$)
Table Global B-cell lymphoma 2 Inhibitors Market Size by Regions 2019-2025 (Million US$)
Table Global B-cell lymphoma 2 Inhibitors Market Share by Regions 2014-2019
Figure Global B-cell lymphoma 2 Inhibitors Market Share by Regions 2014-2019
Figure Global B-cell lymphoma 2 Inhibitors Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global B-cell lymphoma 2 Inhibitors Revenue by by Players (2014-2019) (Million US$)
Table Global B-cell lymphoma 2 Inhibitors Market Share by by Players (2014-2019)
Figure Global B-cell lymphoma 2 Inhibitors Market Share by by Players in 2018
Table Global B-cell lymphoma 2 Inhibitors by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players B-cell lymphoma 2 Inhibitors Product/Solution/Service
Table Date of Enter into B-cell lymphoma 2 Inhibitors Market
Table Mergers & Acquisitions, Expansion Plans
Table Global B-cell lymphoma 2 Inhibitors Market Size by Type (2014-2019) (Million US$)
Table Global B-cell lymphoma 2 Inhibitors Market Size Share by Type (2014-2019)
Figure Global B-cell lymphoma 2 Inhibitors Market Size Market Share by Type (2014-2019)
Table Global B-cell lymphoma 2 Inhibitors Market Size by Application (2014-2019) (Million US$)
Table Global B-cell lymphoma 2 Inhibitors Market Size Share by Application (2014-2019)
Figure Global B-cell lymphoma 2 Inhibitors Market Size Market Share by Application (2014-2019)
Figure Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Application in 2018
Figure North America B-cell lymphoma 2 Inhibitors Market Size 2014-2019 (Million US$)
Table North America Key Players B-cell lymphoma 2 Inhibitors Revenue (2018-2019) (Million US$)
Table North America Key Players B-cell lymphoma 2 Inhibitors Market Share (2018-2019)
Table North America B-cell lymphoma 2 Inhibitors Market Size by Type 2014-2019 (Million US$)
Table North America B-cell lymphoma 2 Inhibitors Market Share by Type 2014-2019
Table North America B-cell lymphoma 2 Inhibitors Market Size by Application 2014-2019 (Million US$)
Table North America B-cell lymphoma 2 Inhibitors Market Share by Application 2014-2019
Figure Europe B-cell lymphoma 2 Inhibitors Market Size 2014-2019 (Million US$)
Table Europe Key Players B-cell lymphoma 2 Inhibitors Revenue (2018-2019) (Million US$)
Table Europe Key Players B-cell lymphoma 2 Inhibitors Market Share (2018-2019)
Table Europe B-cell lymphoma 2 Inhibitors Market Size by Type 2014-2019 (Million US$)
Table Europe B-cell lymphoma 2 Inhibitors Market Share by Type 2014-2019
Table Europe B-cell lymphoma 2 Inhibitors Market Size by Application 2014-2019 (Million US$)
Table Europe B-cell lymphoma 2 Inhibitors Market Share by Application 2014-2019
Figure China B-cell lymphoma 2 Inhibitors Market Size 2014-2019 (Million US$)
Table China Key Players B-cell lymphoma 2 Inhibitors Revenue (2018-2019) (Million US$)
Table China Key Players B-cell lymphoma 2 Inhibitors Market Share (2018-2019)
Table China B-cell lymphoma 2 Inhibitors Market Size by Type 2014-2019 (Million US$)
Table China B-cell lymphoma 2 Inhibitors Market Share by Type 2014-2019
Table China B-cell lymphoma 2 Inhibitors Market Size by Application 2014-2019 (Million US$)
Table China B-cell lymphoma 2 Inhibitors Market Share by Application 2014-2019
Figure Japan B-cell lymphoma 2 Inhibitors Market Size 2014-2019 (Million US$)
Table Japan Key Players B-cell lymphoma 2 Inhibitors Revenue (2018-2019) (Million US$)
Table Japan Key Players B-cell lymphoma 2 Inhibitors Market Share (2018-2019)
Table Japan B-cell lymphoma 2 Inhibitors Market Size by Type 2014-2019 (Million US$)
Table Japan B-cell lymphoma 2 Inhibitors Market Share by Type 2014-2019
Table Japan B-cell lymphoma 2 Inhibitors Market Size by Application 2014-2019 (Million US$)
Table Japan B-cell lymphoma 2 Inhibitors Market Share by Application 2014-2019
Figure Southeast Asia B-cell lymphoma 2 Inhibitors Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players B-cell lymphoma 2 Inhibitors Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players B-cell lymphoma 2 Inhibitors Market Share (2018-2019)
Table Southeast Asia B-cell lymphoma 2 Inhibitors Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia B-cell lymphoma 2 Inhibitors Market Share by Type 2014-2019
Table Southeast Asia B-cell lymphoma 2 Inhibitors Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia B-cell lymphoma 2 Inhibitors Market Share by Application 2014-2019
Figure India B-cell lymphoma 2 Inhibitors Market Size 2014-2019 (Million US$)
Table India Key Players B-cell lymphoma 2 Inhibitors Revenue (2018-2019) (Million US$)
Table India Key Players B-cell lymphoma 2 Inhibitors Market Share (2018-2019)
Table India B-cell lymphoma 2 Inhibitors Market Size by Type 2014-2019 (Million US$)
Table India B-cell lymphoma 2 Inhibitors Market Share by Type 2014-2019
Table India B-cell lymphoma 2 Inhibitors Market Size by Application 2014-2019 (Million US$)
Table India B-cell lymphoma 2 Inhibitors Market Share by Application 2014-2019
Figure Central & South America B-cell lymphoma 2 Inhibitors Market Size 2014-2019 (Million US$)
Table Central & South America Key Players B-cell lymphoma 2 Inhibitors Revenue (2018-2019) (Million US$)
Table Central & South America Key Players B-cell lymphoma 2 Inhibitors Market Share (2018-2019)
Table Central & South America B-cell lymphoma 2 Inhibitors Market Size by Type 2014-2019 (Million US$)
Table Central & South America B-cell lymphoma 2 Inhibitors Market Share by Type 2014-2019
Table Central & South America B-cell lymphoma 2 Inhibitors Market Size by Application 2014-2019 (Million US$)
Table Central & South America B-cell lymphoma 2 Inhibitors Market Share by Application 2014-2019
Table AbbVie Inc. Company Details
Table AbbVie Inc. Revenue in B-cell lymphoma 2 Inhibitors Business 2014-2019 (Million US$)
Figure AbbVie Inc. Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2014-2019)
Table AbbVie Inc. Recent Development
Table F. Hoffmann-La Roche Ltd. Company Details
Table F. Hoffmann-La Roche Ltd. Revenue in B-cell lymphoma 2 Inhibitors Business 2014-2019 (Million US$)
Figure F. Hoffmann-La Roche Ltd. Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2014-2019)
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Santa Cruz Biotechnology Company Details
Table Santa Cruz Biotechnology Revenue in B-cell lymphoma 2 Inhibitors Business 2014-2019 (Million US$)
Figure Santa Cruz Biotechnology Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2014-2019)
Table Santa Cruz Biotechnology Recent Development
Table Tocris Company Details
Table Tocris Revenue in B-cell lymphoma 2 Inhibitors Business 2014-2019 (Million US$)
Figure Tocris Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2014-2019)
Table Tocris Recent Development
Table Biovision Company Details
Table Biovision Revenue in B-cell lymphoma 2 Inhibitors Business 2014-2019 (Million US$)
Figure Biovision Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2014-2019)
Table Biovision Recent Development
Table Global B-cell lymphoma 2 Inhibitors Market Size by Regions (Million US$) 2019-2025
Figure Global B-cell lymphoma 2 Inhibitors Market Size Share by Regions (2019-2025)
Figure Global B-cell lymphoma 2 Inhibitors Market Size Share by Regions in 2025
Figure North America B-cell lymphoma 2 Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Europe B-cell lymphoma 2 Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure China B-cell lymphoma 2 Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Japan B-cell lymphoma 2 Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia B-cell lymphoma 2 Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure India B-cell lymphoma 2 Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America B-cell lymphoma 2 Inhibitors Market Size Forecast (2019-2025)(Million USD)
Table Global B-cell lymphoma 2 Inhibitors Market Size by Product (2019-2025) (Million US$)
Figure Global B-cell lymphoma 2 Inhibitors Market Size by Product (2019-2025)
Figure Global B-cell lymphoma 2 Inhibitors Market Size by Product in 2025
Table Global B-cell lymphoma 2 Inhibitors Market Size by Application (2019-2025) (Million US$)
Figure Global B-cell lymphoma 2 Inhibitors Market Size by Application (2019-2025)
Figure Global B-cell lymphoma 2 Inhibitors Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
BCL-2（B細胞リンパ腫2）阻害剤のグローバル市場：規模・現状・予測2019-2025 Symptoms of hematologic malignancies are usually mild or inconspicuous, leading to delays in diagnosis and treatment of indications.BCL-2 (B-cell lymphoma 2) inhibitors regulates the correlation of cell apoptosis at the mitochondrial level, which has the potential to be a therapeutic target for hem…- B細胞慢性リンパ性白血病の治療のグローバル市場調査 2019年 The global B-Cell Chronic Lymphocytic Leukemia Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on B-Cell Chronic Lymphocytic Leukemia Treatment volume and value at global level, regional leve…
- マントル細胞リンパ腫治療法のグローバル市場：規模・現状・予測2019-2025 Mantle cell lymphoma (MCL) is a heterogeneous aggressive disease and remains incurable with current chemotherapies. The development of monoclonal antibody (mAb) has led to substantial achievement in immunotherapeutic strategies for B-cell lymphomas including MCL.Nonetheless, progress in the clinical…
- 世界及び中国のびまん性大細胞型B細胞リンパ腫市場2018 The 'Global and Chinese Diffuse Large B Cell Lymphoma Drug Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Diffuse Large B Cell Lymphoma Drug industry with a focus on the Chinese market. The report provides key statistics on the mar…
- 世界の有毛細胞白血病治療産業調査2019-2025 Hairy cell leukemia is a slow-growing, rare type of chronic cell leukemia.In 2018, the global Hairy Cell Leukemia Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 20…